Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS

Approved

STANDARD

ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS

Eli Lilly Nederland B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jan 8, 2024
Approval ID: f0ea7eb2a7cd9c68
Company: Eli Lilly Nederland B.V.
Type: Standard

Approval Details

Approval Id: f0ea7eb2a7cd9c68
Drug Cima Aemps Name: ZYPREXA 5 MG COMPRIMIDOS RECUBIERTOS
Register Number: 96022004IP5
Holder Company Name: Eli Lilly Nederland B.V.
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/eli-lilly-nederland-bv
Authorization Date: 2024-01-08
Dosage Form: COMPRIMIDO RECUBIERTO
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Eli Lilly Nederland B.V.
Company Detail Path: /organization/eli-lilly-nederland-bv

Company Information

Pharmaceutical Company Name: Eli Lilly Nederland BV
Country Name: Netherlands
Website: http://www.lilly.com/nl

Active Ingredients

OLANZAPINA

5 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 8, 2024

Approval ID

f0ea7eb2a7cd9c68

Type

Standard

Back to CIMA-AEMPS Approvals